These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22036802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A, Reid K, Young AH, Macritchie K, Geddes J.
    Cochrane Database Syst Rev; 2013 Oct 17; 2013(10):CD003196. PubMed ID: 24132760
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov 17; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 5. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW.
    J Clin Psychiatry; 2003 Jul 17; 64(7):841-6. PubMed ID: 12934987
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
    Am J Psychiatry; 2005 Jul 17; 162(7):1281-90. PubMed ID: 15994710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
    Am J Psychiatry; 2003 Jul 17; 160(7):1263-71. PubMed ID: 12832240
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
    Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR.
    J Clin Psychiatry; 2009 Jan 17; 70(1):113-21. PubMed ID: 19192457
    [Abstract] [Full Text] [Related]

  • 11. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR.
    Br J Psychiatry; 2004 Apr 17; 184():337-45. PubMed ID: 15056579
    [Abstract] [Full Text] [Related]

  • 12. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ.
    J Clin Psychiatry; 2006 Aug 17; 67(8):1246-52. PubMed ID: 16965203
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
    Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL.
    Am J Psychiatry; 2005 Nov 17; 162(11):2152-61. PubMed ID: 16263857
    [Abstract] [Full Text] [Related]

  • 16. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
    Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.
    Bipolar Disord; 2012 Nov 17; 14(7):780-9. PubMed ID: 23107222
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine in long-term treatment for bipolar disorder.
    Cipriani A, Rendell JM, Geddes J.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD004367. PubMed ID: 19160237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jan 21; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 20. Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
    Houston JP, Ketter TA, Case M, Bowden C, Degenhardt EK, Jamal HH, Tohen M.
    J Psychiatr Res; 2011 Feb 21; 45(2):169-73. PubMed ID: 20541220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.